Thrilled to share our new review on the genomic and molecular drivers of #MultipleMyeloma! 🧬✨ We dive into the latest discoveries, their impact on disease progression, and how they inform therapeutic strategies. Check it out: www.dovepress.com/articles.php...

Hello #ASH24! Come meet me tonight at the poster session: paper #4658 on immune features of myeloma subtypes.

Excited to share our latest work in #MultipleMyeloma! 🧬 We uncovered a six-gene signature predicting response to venetoclax, but also revealed that 1q gain can drive resistance—and how CDK7 inhibitors might reverse it. #MyelomaResearch

Hello, Bluesky! 👋 Thrilled to join this space. I’m an Asst Prof working at the intersection of #CancerGenomics and computational biology, with a focus on high-risk #MultipleMyeloma. Looking forward to connecting with researchers, clinicians, and anyone passionate about advancing #MyelomaResearch! 🧬✨